SARS-CoV-2 alpha variant: is it really more deadly? A population level observational study
View ORCID ProfileCandace Makeda Moore, View ORCID ProfileRuslan Sergienko, View ORCID ProfileRonen Arbel
doi: https://doi.org/10.1101/2021.08.17.21262167
Candace Makeda Moore
1Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel
MD.Ruslan Sergienko
2Department of Health Policy and Management, Ben-Gurion University of the Negev, Beer Sheva, Israel
MARonen Arbel
1Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel
PhD.Article usage
Posted August 18, 2021.
SARS-CoV-2 alpha variant: is it really more deadly? A population level observational study
Candace Makeda Moore, Ruslan Sergienko, Ronen Arbel
medRxiv 2021.08.17.21262167; doi: https://doi.org/10.1101/2021.08.17.21262167
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2936)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12740)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4579)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4346)
- Nursing (236)
- Nutrition (638)
- Oncology (2268)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)